Potential Side Effects and Digestive Changes The most common adverse effects of Wegovy involve the gastrointestinal system, with nausea, diarrhoea, vomiting, constipation, and abdominal pain reported in clinical trials, as detailed in the MHRA-approved SmPC
The FDA-approved dose for weight management is 2.4 mg weekly (Wegovy), which is higher than the 0.5-1.0 mg doses used for diabetes management
For only GSSG quantification samples and the standard are treated with 4-vinylpyridine for an hour before performing glutathione assay and thus GSH is removed and only GSSG concentration is determined.
Vasquez A, Buraniqi E, Wirrell EC
PlexusDx recommends working with your prescriber to monitor food intake and nutritional markers, especially protein consumption, which supports muscle preservation during weight loss
This hormone performs several key functions: Insulin Secretion: It tells the pancreas to release insulin when blood sugar levels are high